Gene structure and organization of the human β‐secretase ( BACE ) promoter
Open Access
- 1 April 2004
- journal article
- fj express-summary
- Published by Wiley in The FASEB Journal
- Vol. 18 (9) , 1034-1036
Abstract
The first step in the generation of the amyloid‐β peptide (Aβ) deposited in the brains of patients with Alzheimer's disease (AD) is the processing of the larger Aβ precursor protein (APP) by an integral membrane aspartyl protease named the β‐site APP‐cleaving enzyme (BACE). We present the genomic organization of the BACE gene. BACE mRNAs are synthesized as nine exons and eight introns from a 30.6 kb region of chromosome 11q23.2–11q23.3. Regulation of BACE may play an important role in regulating the levels of Aβ produced and is therefore likely to play an important role in AD. Herein, we report the cloning and detailed analysis of 3765 nucleotides of the promoter region of BACE and 364 nucleotides of the 5′ untranslated region of the BACE mRNA (5′ UTR). Characteristic “CAAT” and “TATA” boxes are absent within 1.5 kb of the transcription start site (TSS). The promoter region and 5′ UTR contain multiple transcription factor binding sites, such as activator protein (AP)1, AP2, cAMP response element binding protein (CREB), estrogen responsive element (ERE), glucocorticoid responsive element (GRE), “GC” box, nuclear factor (NF)‐κB, signal transducer and activator of transcription (STAT)1, stimulating protein (SP)1, metal‐regulatory elements, and possible Zeste binding sites. Limited interspecies similarity was observed between the human sequence and corresponding genomic DNA from the rat and mouse sequences, but several transcription factor‐binding sites are conserved. Thus, the BACE gene contains basal regulatory elements, inducible features and sites for regulated activity by various transcription factors. These results identify the important regions for functional analysis of the binding domains and neuron‐specific expression (1). Such a study will allow us to further examine the possible role of changes in the promoter of BACE in AD pathogenesis.Keywords
Funding Information
- National Institutes of Health (AG18379, AG18884)
- Alzheimer's Association (IIRG2056, IIRG3062)
This publication has 39 references indexed in Scilit:
- A Critical Analysis of New Molecular Targets and Strategies for Drug Developments in Alzheimers DiseaseCurrent Drug Targets, 2003
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor proteinProceedings of the National Academy of Sciences, 2000
- Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activityNature, 1999
- Purification and cloning of amyloid precursor protein β-secretase from human brainNature, 1999
- Identification of a Novel Aspartic Protease (Asp 2) as β-SecretaseMolecular and Cellular Neuroscience, 1999
- β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACEScience, 1999
- Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein PrecursorScience, 1993
- Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein productionNature, 1992
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992